Lessee, Operating Lease, Liability, to be Paid, Year Three of LIFECORE BIOMEDICAL, INC. \DE\ from 25 Aug 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
LIFECORE BIOMEDICAL, INC. \DE\ quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 25 Aug 2019 to 30 Sep 2025.
  • LIFECORE BIOMEDICAL, INC. \DE\ Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2025 was $144,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

LIFECORE BIOMEDICAL, INC. \DE\ Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $144,000 30 Sep 2025 10-Q 06 Nov 2025 2026 Q1
Q2 2025 $302,000 -$114,000 -27% 25 May 2025 10-K 07 Aug 2025 2025 FY
Q1 2025 $302,000 23 Feb 2025 10-Q 03 Apr 2025 2025 Q3
Q2 2024 $416,000 -$812,000 -66% 26 May 2024 10-K 26 Aug 2024 2024 FY
Q2 2023 $1,228,000 -$774,000 -39% 28 May 2023 10-K 20 Mar 2024 2023 FY
Q2 2022 $2,002,000 -$1,261,000 -39% 29 May 2022 10-K/A 16 Mar 2023 2022 FY
Q2 2021 $3,263,000 -$546,000 -14% 30 May 2021 10-K 29 Jul 2021 2021 FY
Q2 2020 $3,809,000 31 May 2020 10-K 14 Aug 2020 2020 FY
Q1 2020 $4,350,000 23 Feb 2020 10-Q 03 Apr 2020 2020 Q3
Q4 2019 $4,283,000 24 Nov 2019 10-Q 02 Jan 2020 2020 Q2
Q3 2019 $3,522,000 25 Aug 2019 10-Q 03 Oct 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.